Cargando…
VX-166, a novel potent small molecule caspase inhibitor, as a promising new treatment for sepsis
Autores principales: | Weber, P, Wang, P, Wu, R, Miksa, M, Dong, W, Ku, G, Dawson, D, Miller, K, Charlton, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092527/ http://dx.doi.org/10.1186/cc4499 |
Ejemplares similares
-
VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis
por: Weber, Peter, et al.
Publicado: (2009) -
Caspase-1 and ASC but not NLRP3 mediate antifungal defense in candidiasis sepsis
por: Veerdonk, F van de, et al.
Publicado: (2009) -
Caspase-1-deficient mice are more resistant to severe sepsis
por: Sônego, F, et al.
Publicado: (2009) -
P166: Improving children's and their visitors' hand hygiene compliance
por: Lary, D, et al.
Publicado: (2013) -
P166 Measures of overnight sleep stability in patients with hypersomnolence
por: Woods, S, et al.
Publicado: (2021)